Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Receivables - Other: 2019-2020

  • Benitec Biopharma's Receivables - Other was N/A to $21,000 in Q4 2020 from the same period last year, while for Dec 2020 it was $21,000, marking a year-over-year change of. This contributed to the annual value of $59,000 for FY2020, which is 96.89% down from last year.
  • Per Benitec Biopharma's latest filing, its Receivables - Other stood at $21,000 for Q4 2020, which was down 64.41% from $59,000 recorded in Q2 2020.
  • In the past 5 years, Benitec Biopharma's Receivables - Other registered a high of $1.9 million during Q2 2019, and its lowest value of $21,000 during Q4 2020.
  • Over the past 2 years, Benitec Biopharma's median Receivables - Other value was $59,000 (recorded in 2020), while the average stood at $660,000.
  • Data for Benitec Biopharma's Receivables - Other shows a maximum YoY crashed of 96.89% (in 2020) over the last 5 years.
  • Over the past 2 years, Benitec Biopharma's Receivables - Other (Quarterly) stood at $1.9 million in 2019, then plummeted by 96.89% to $21,000 in 2020.
  • Its Receivables - Other stands at $21,000 for Q4 2020, versus $59,000 for Q2 2020 and $1.9 million for Q2 2019.